Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000669361 | SCV000794108 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2017-09-13 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV001268203 | SCV001446954 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453287 | SCV004182827 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453286 | SCV004182828 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003453287 | SCV004206418 | pathogenic | Retinitis pigmentosa 39 | 2022-05-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001268203 | SCV004292392 | pathogenic | not provided | 2023-03-18 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 553836). This premature translational stop signal has been observed in individual(s) with clinical features of Usher syndrome (PMID: 28944237). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Pro2747Hisfs*22) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). |